MedTrace Logo

Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation

NCT06429748 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-05-08

No results posted yet for this study

Summary

A prospective study to evaluate symptoms following repetitive transcranial Magnetic stimulation.

Conditions

  • Neurologic Symptoms

Interventions

DEVICE

rTMS

repetitive Transcranial Magnetic Stimultion

Sponsors & Collaborators

  • Neuronetics

    lead OTHER

Principal Investigators

  • Steve Erickson · Neuronetics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2025-04-29
Completion
2027-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06429748 on ClinicalTrials.gov